PEspeaks

Aug 07, 2017
Pharmaceutical Executive
A review of the top contenders to land the agency as decision on its relocation draws closer.
Aug 04, 2017
Pharmaceutical Executive
The growing toll requires new assessment of risks, expanded provider education, and more scrutiny of marketed products.
Aug 03, 2017
Pharmaceutical Executive
The agency’s new commissioner unveiled new digital health pilot programs to help navigate regulatory requirements.
Jul 28, 2017
The UK is entering into unchartered waters between Brexit – offering potentially new approaches to procurement – and negotiating a successor to the PPRS. The government's new recruit Steve Oldfield could give it the inside track, writes Leela Barham.
Jul 24, 2017
The era of complex biological drugs requires sales reps with more advanced knowledge, write Bagrat Lalayan.
Jul 21, 2017
The UK's proposed Accelerated Access Review is being dogged by delay and disappointment, writes Leela Barham.
Jul 18, 2017
The Association of the British Pharmaceutical Industry is seeking permission for a Judicial Review of NICE's affordability proposals. Leela Barham reports.
Jul 17, 2017
Pharmaceutical Executive
While it’s easy to get excited about new gadgets, remember that the overall goal of mHealth and social media must be to deepen relationships and communication.
Jul 14, 2017
With the US Institute for Clinical and Economic Review (ICER) looking like it is here to stay, Leela Barham reviews its value framework.
Jul 13, 2017
In the second of her articles on value assessment, Leela Barham discusses the emergence of multiple frameworks in the US and considers their impact.
native1_300x100
lorem ipsum